Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3541111000168117 | Restavit (doxylamine succinate 25 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3541121000168112 | Restavit 25 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Restavit 25 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Restavit 25 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Restavit 25 mg tablet | Is a | Restavit | true | Inferred relationship | Some | ||
| Restavit 25 mg tablet | Is a | doxylamine succinate 25 mg tablet | true | Inferred relationship | Some | ||
| Restavit 25 mg tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Restavit 25 mg tablet | has Australian BoSS | doxylamine succinate | true | Inferred relationship | Some | 88515962 | |
| Restavit 25 mg tablet | has intended active ingredient | doxylamine | true | Inferred relationship | Some | 88515962 | |
| Restavit 25 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 88515963 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Restavit 25 mg tablet, 20 | has TPUU | True | Restavit 25 mg tablet | Inferred relationship | Some | 1 |
| Restavit 25 mg tablet, 20, blister pack | has TPUU | True | Restavit 25 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR